Advertisement

Effects of prolonged ethanol lock exposure to carbothane- and silicone-based hemodialysis catheters: a 26-week study

Effects of prolonged ethanol lock exposure to carbothane- and silicone-based hemodialysis catheters: a 26-week study

J Vasc Access 2015; 16(5): 367 - 371

Article Type: ORIGINAL ARTICLE

DOI:10.5301/jva.5000397

Authors

Daniel L. Landry, Randa A. Jaber, Nandheesha Hanumanthappa, George S. Lipkowitz, Michael H. O’Shea, Harry Bermudez, Adam P. Hathorne, Gregory L. Braden

Abstract

Antibiotic locks in catheter-dependent chronic hemodialysis patients reduce the rate of catheter-related bloodstream infections (CRBSIs), but may be associated with the development of resistant bacteria. Ethanol-based catheter locks may provide a better alternative; however, there are limited data on the long-term integrity of dialysis catheters exposed to ethanol.

We performed in vitro testing of two types of hemodialysis catheters—silicone (SLC) and carbothane (CBT) based—with a 70% ethanol lock (EL) versus heparin lock (HL) for 26 weeks. Lock solutions were changed thrice weekly to mimic a conventional hemodialysis schedule. We tested mechanical properties of the catheters at 0, 13 and 26 weeks by examining stress/strain relationships (SS400%) and modulus of elasticity (ME). Electron microscopy was performed to examine catheter ultrastructure at 0 and 26 weeks.

Catheter integrity for HL versus EL in SLC (SS400%: 4.5 vs. 4.5 MPa, p = NS; ME: 4.6 vs. 4.7 MPa, p = NS) or CBT-based catheters (SS400%: 7.6 vs. 8.9 MPa, p = NS; ME: 9.6 vs. 12.2 MPa, p = NS) were all similar at 13 and 26 weeks. Scanning electron microscopy revealed no structural changes in the central and luminal wall internal surfaces of EL- versus HL-treated catheters.

There were no significant differences in catheter integrity between SLC or CBT catheters exposed to a 70% EL for 26 weeks. Given its low cost, potential to avoid antibiotic resistance and structural integrity after 6 months of high-dose ethanol, ELs should be studied prospectively against antibiotic locks to assess the efficacy and safety in hemodialysis patients.

Article History

Disclosures

Financial support: None.
Conflict of interest: None.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Landry, Daniel L. [PubMed] [Google Scholar] 1, 2, * Corresponding Author (daniel.landry@bhs.org)
  • Jaber, Randa A. [PubMed] [Google Scholar] 1, 2
  • Hanumanthappa, Nandheesha [PubMed] [Google Scholar] 1, 2
  • Lipkowitz, George S. [PubMed] [Google Scholar] 1, 2
  • O’Shea, Michael H. [PubMed] [Google Scholar] 1, 2
  • Bermudez, Harry [PubMed] [Google Scholar] 3
  • Hathorne, Adam P. [PubMed] [Google Scholar] 3
  • Braden, Gregory L. [PubMed] [Google Scholar] 1, 2

Affiliations

  • Baystate Medical Center, Springfield, MA - USA
  • Tufts University School of Medicine, Boston, MA - USA
  • University of Massachusetts Polymer Science & Engineering, Amherst, MA - USA

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.